UGT2B17 modifies drug response in chronic lymphocytic leukaemia.
Allain EP, Rouleau M, Vanura K, Tremblay S, Vaillancourt J, Bat V, Caron P, Villeneuve L, Labriet A, Turcotte V, Le T, Shehata M, Schnabl S, Demirtas D, Hubmann R, Joly-Beauparlant C, Droit A, Jäger U, Staber PB, Lévesque E, Guillemette C.
Allain EP, et al. Among authors: hubmann r.
Br J Cancer. 2020 Jul;123(2):240-251. doi: 10.1038/s41416-020-0887-6. Epub 2020 May 18.
Br J Cancer. 2020.
PMID: 32418995
Free PMC article.